AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (783 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

Muse cells and Neurorestoratology

Zikuan Leng1Nikhit Kethidi2Allen J. Chang2Lijun Sun1Jingjing Zhai1Yiting Yang1Jianzhong Xu3Xijing He1( )
Department of Orthopaedics, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China
W. M. Keck Center for Collaborative Neuroscience, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08901-8554, USA
Department of Orthopaedics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Show Author Information

Abstract

Multilineage-differentiating stress-enduring (Muse) cells were discovered in 2010 as a subpopulation of mesenchymal stroma cells (MSCs). Muse cells can self-renew and tolerate severe culturing conditions. These cells can differentiate into three lineage cells spontaneously or in induced medium but do not form teratoma in vitro or in vivo. Central nervous system (CNS) diseases, such as intracerebral hemorrhage (ICH), cerebral infarction, and spinal cord injury are normally disastrous. Despite numerous therapy strategies, CNS diseases are difficult to recover. As a novel kind of pluripotent stem cells, Muse cells have shown great regeneration capacity in many animal models, including acute myocardial infarction, hepatectomy, and acute cerebral ischemia (ACI). After injection into injury sites, Muse cells survived, migrated, and differentiated into functional neurons with synaptic junctions to local neurons and contributed to recovery of function. Furthermore, Muse cell differentiation did not need to be induced pre-transplantation and no tumors were observed post- transplantation. The Muse cell population is promising and may lead to a revolution in regenerative medicine. This review focuses on recent advances regarding the Muse cells therapies in Neurorestoratology and discusses future perspectives in this field.

References

[1]
Y Kuroda,, M Kitada, S Wakao, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA. 2010, 107(19): 8639-8643.
[2]
Y Kuroda,, S Wakao, M Kitada, et al. Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat Protoc. 2013, 8(7): 1391-1415.
[3]
S Wakao, H Akashi, Y Kushida, et al. Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues. Pathol Int. 2014, 64(1): 1-9.
[4]
S Wakao, M Kitada, Y Kuroda, et al. Multilineage- differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci USA. 2011, 108(24): 9875-9880.
[5]
M Dezawa,. Muse cells provide the pluripotency of mesenchymal stem cells: Direct contribution of muse cells to tissue regeneration. Cell Transplant. 2016, 25(5): 849-861.
[6]
S Heneidi,, AA Simerman, E Keller, et al. Awakened by cellular stress: Isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PLoS ONE. 2013, 8(7): e64752.
[7]
T Yamauchi, K Yamasaki, K Tsuchiyama, et al. A quantitative analysis of multilineage-differentiating stress- enduring (Muse) cells in human adipose tissue and efficacy of melanocytes induction. J Dermatol Sci. 2017, 86(3): 198-205.
[8]
K Tsuchiyama, S Wakao, Y Kuroda, et al. Functional melanocytes are readily reprogrammable from multilineage- differentiating stress-enduring (Muse) cells, distinct stem cells in human fibroblasts. J Investigat Dermatol. 2013, 133(10): 2425-2435.
[9]
H Katagiri, Y Kushida, M Nojima, et al. A distinct subpopulation of bone marrow mesenchymal stem cells, Muse cells, directly commit to the replacement of liver components. Am J Transplant. 2016, 16(2): 468-483.
[10]
F Ogura, S Wakao, Y Kuroda, et al. Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: Potential implications in regenerative medicine. Stem Cells Dev. 2014, 23(7): 717-728.
[11]
H Yabuki, S Wakao, Y Kushida, et al. Human multilineage- differentiating stress-enduring cells exert pleiotropic effects to ameliorate acute lung ischemia-reperfusion injury in a rat model. Cell Transplant. 2018, 27(6): 979-993.
[12]
N Uchida, Y Kushida, M Kitada, et al. Beneficial effects of systemically administered human Muse cells in adriamycin nephropathy. J Am Soc Nephrol. 2017, 28(10): 2946-2960.
[13]
M Iseki, Y Kushida, S Wakao, et al. Human Muse Cells, nontumorigenic pluripotent-like stem cells, have liver regeneration capacity through specific homing and cell replacement in a mouse model of liver fibrosis. Cell Transplant. 2017, 26(5): 821-840.
[14]
M Amin, Y Kushida, S Wakao, et al. Cardiotrophic growth factor-driven induction of human Muse Cells into cardiomyocyte-like phenotype. Cell Transplant. 2018, 27(2): 285-298.
[15]
H Uchida, K Niizuma, Y Kushida, et al. Human Muse cells reconstruct neuronal circuitry in subacute lacunar stroke model. Stroke. 2017, 48(2): 428-435.
[16]
T Yamasaki, S Wakao, H Kawaji, et al. Genetically engineered multilineage-differentiating stress-enduring cells as cellular vehicles against malignant gliomas. Mol Ther Oncolytics. 2017(6): 45-56.
[17]
ML Gimeno, F Fuertes, AEB Tabarrozzi, et al. Pluripotent nontumorigenic adipose tissue-derived Muse cells have immunomodulatory capacity mediated by transforming growth factor-β1. Stem Cell Transl Med. 2017, 6(1): 161-173.
[18]
DJ Prockop. Repair of tissues by adult stem/progenitor cells (MSCs): Controversies, myths, and changing paradigms. Mol Ther. 2009, 17(6): 939-946.
[19]
J Huang, Z Zhang, J Guo, et al. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res. 2010, 106(11): 1753-1762.
[20]
F Ceteci, S Ceteci, C Karreman, et al. Disruption of tumor cell adhesion promotes angiogenic switch and progression to micrometastasis in RAF-Driven murine lung cancer. Cancer Cell. 2007, 12(2): 145-159.
[21]
JE Thornton, RI Gregory. How does Lin28 let-7 control development and disease? Trends Cell Biol. 2012, 22(9): 474-482.
[22]
Y Yamada, S Wakao, Y Kushida, et al. S1P-S1PR2 axis mediates homing of Muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction. Circ Res. 2018, 122(8): 1069-1083.
[23]
P Connick, M Kolappan, C Crawley, et al. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: An open-label phase 2a proof-of-concept study. Lancet Neurol. 2012, 11(2): 150-156.
[24]
OY Bang, JS Lee, PH Lee, et al. Autologous mesenchymal stem cell transplantation in stroke patients. Annals of Neurology. 2005, 57(6): 874-882.
[25]
K Takahashi, S Yamanaka. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006, 126(4): 663-676.
[26]
M Kitada, S Wakao, M Dezawa. Muse cells and induced pluripotent stem cell: Implication of the elite model. M Cell Mol Life Sci. 2012, 69(22): 3739-3750.
[27]
T Tanaka, K Nishigaki, S Minatoguchi, et al. Mobilized Muse cells after acute myocardial infarction predict cardiac function and remodeling in the chronic phase. Circ J. 2018, 82(2): 561-571.
[28]
N Alessio,, et al., Stress and stem cells: Adult Muse cells tolerate extensive genotoxic stimuli better than mesenchymal stromal cells. Oncotarget. 2018, 9(27): 19328-19341.
[29]
E Toyoda, M Sato, T Takahashi, et al. Multilineage- differentiating stress-enduring (Muse)-like cells exist in synovial tissue. Regen therapy. 2019,10: 17-26.
[30]
M Dezawa. The Muse cell discovery, thanks to wine and science. Adv Exp Med Biol. 2018, 1103: 1-11.
[31]
K Kinoshita, S Kuno, H Ishimine, et al. Therapeutic potential of adipose-derived SSEA-3-positive Muse cells for treating diabetic skin ulcers. Stem Cell Transl Med. 2015, 4(2): 146-155.
[32]
KW Culver, Z Ram, S Wallbridge, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 1992, 256(5063): 1550-1552.
[33]
T Yamauchi, Y Kuroda, T Morita, et al. Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PLoS ONE. 2015, 10(3): e0116009.
[34]
N Shimamura, K Kakuta, L Wang, et al. Neuro-regeneration therapy using human Muse cells is highly effective in a mouse intracerebral hemorrhage model. Exp Brain Res. 2017, 235(2): 565-572.
[35]
X Chen, ML Xu, CN Wang, et al. A partition-type tubular scaffold loaded with PDGF-releasing microspheres for spinal cord repair facilitates the directional migration and growth of cells. Neural Regen Res. 2018, 13(7): 1231-1240.
[36]
AA Simerman, DA Dumesic, GD Chazenbalk. Pluripotent muse cells derived from human adipose tissue: A new perspective on regenerative medicine and cell therapy. Clin transl med. 2014, 12(3): 12.
[37]
E Hori, Y Hayakawa, T Hayashi, et al. Mobilization of pluripotent multilineage-differentiating stress-enduring cells in ischemic stroke. J Stroke Cerebrovasc. 2016, 25(6): 1473-1481.
[38]
AI Caplan. Mesenchymal stem-cells. J Orthop Res. 1991, 9(5): 641-650.
[39]
EM Horwitz, KL Blanc, M Dominici, et al. Clarification of the nomenclature for MSC: The international society for cellular therapy position statement. Cytotherapy. 2005, 7(5): 393-395.
[40]
M Dominici, KL Blanc, I Mueller, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006, 8(4): 315-317.
[41]
J Galipeau, M Krampera, J Barrett, et al. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2016, 18(2): 151-159.
[42]
D Sipp, PG Robey, L Turner. Clear up this stem-cell mess. Nature. 2018, 561(7724): 455-457.
[43]
TJ Cashman, V Gouon-Evans, KD Costa. Mesenchymal stem cells for cardiac therapy: Practical challenges and potential mechanisms. Stem Cell Rev Rep. 2013, 9(3): 254-265.
[44]
AI Caplan. Mesenchymal stem cells: Time to change the name!. Stem Cell Transl Med. 2017, 6(6): 1445-1451.
[45]
HY Huang, GS Mao, L Chen. Current status and prospect of cell therapy in neurorestoration. Chin J Cell Stem Cell (Electronic Edition). 2017, 7(3): 162-167.
[46]
Z Shi, HY Huang, SQ Feng. Stem cell-based therapies to treat spinal cord injury: A review. J Neurorestoratol. 2017, 5(1): 125-131.
[47]
U Kunter, S Rong, Z Djuric, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol. 2006, 17(8): 2202-2212.
[48]
EE Mahmoud,, N Kamei, R Shimizu, et al. Therapeutic potential of multilineage-differentiating stress-enduring cells for osteochondral repair in a rat model. Stem Cells Int. 2017, 2017: 8154569.
[49]
T Yamauchi, K Yamasaki, K Tsuchiyama, et al. The potential of Muse Cells for regenerative medicine of skin: Procedures to reconstitute skin with Muse cell-derived keratinocytes, fibroblasts, and melanocytes. J Invest Dermatol. 2017, 137(12): 2639-2642.
[50]
R Kurose, T Sawai, K Oishi, et al. Possibility of inhibiting arthritis and joint destruction by SSEA-3 positive cells derived from synovial tissue in rheumatoid arthritis. Regenerative Therapy. 2017, 7: 82-88.
[51]
M Iseki, Y Kushida, S Wakao, et al. Muse Cells, nontumorigenic pluripotent-like stem cells, have liver regeneration capacity through specific homing and cell replacement in a mouse model of liver fibrosis. Cell Transplant. 2017, 26(5): 821-840.
[52]
K Hosoyama, S Wakao, Y Kushida, et al. Intravenously injected human multilineage-differentiating stress-enduring cells selectively engraft into mouse aortic aneurysms and attenuate dilatation by differentiating into multiple cell types. J Cardiovasc Surg. 2018, 155(6): 2301-2313.e4.
Journal of Neurorestoratology
Pages 18-25
Cite this article:
Leng Z, Kethidi N, Chang AJ, et al. Muse cells and Neurorestoratology. Journal of Neurorestoratology, 2019, 7(1): 18-25. https://doi.org/10.26599/JNR.2019.9040005

676

Views

33

Downloads

5

Crossref

5

Web of Science

0

Scopus

Altmetrics

Received: 11 December 2018
Revised: 24 January 2019
Accepted: 28 January 2019
Published: 22 March 2019
© The authors 2019

This article is published with open access at http://jnr.tsinghuajournals.com

Return